Combined Administration of Recombinant Human Megakaryocyte Growth and Development Factor and Granulocyte Colony-stimulating Factor Enhances Multilineage Hematopoietic Reconstitution in Nonhuman Primates After Radiation-induced Marrow Aplasia

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1996 May 1

PMID 8621805

Citations 25

Authors

A M Farese

P Hunt

L B Grab

T J MacVittie

Affiliations

Soon will be listed here.

Abstract

This study compared the therapeutic potential of recombinant, native versus pegylated megakaryocyte growth and development factor (rMGDF and PEG-rMGDF, respectively), as well as that of the combined administration of PEG-rMGDF and r-methionyl human granulocyte colony-stimulating factor (r-metHuG-CSF) on hematopoietic reconstitution after 700 cGy, 60Co gamma, total body irradiation in nonhuman primates. After total body irradiation, animals received either rMGDF, PEG-rMGDF, r-metHuG-CSF, PEG-rMGDF and r-metHuG-CSF or HSA. Cytokines in all MGDF protocols were administered for 21-23 d. Either rMGDF, PEG-rMGDF, or PEG-rMGDF and r-metHuG-CSF administration significantly diminished the thrombocytopenic duration (platelet count (PLT) < 20,000 per microliter)to o.25, 0, 0.5 d, respectively, and the severity of the PLT nadir (28,000, 43,000, and 30,000 per microliter, respectively) as compared with the controls (12.2 d duration, nadir 4,000 per microliter), and elicited an earlier PLT recovery. Neutrophil regeneration was augmented in all cytokine protocols and combined PEG-rMGDF and r-metHuG-CSF further decreased the duration of neutropenia compared with r-metHuG-CSF alone. These data demonstrated that the administration of PEG-rMGDF significantly induced bone marrow regeneration versus rMGDF, and when combined with r-metHuG-CSF significantly enhanced multilineage hematopoietic recovery with no evidence of lineage competition.

Citing Articles

PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injury.

Holmes-Hampton G, Kumar V, Biswas S, Stone S, Sharma N, Legesse B Sci Rep. 2023; 13(1):15211.

PMID: 37709916 PMC: 10502090. DOI: 10.1038/s41598-023-42443-0.

Meeting Commentary: A Poly-Pharmacy Approach to Mitigate Acute Radiation Syndrome (ARS).

Satyamitra M, Cassatt D, Taliaferro L Radiat Res. 2021; 196(4):423-428.

PMID: 34270773 PMC: 8522554. DOI: 10.1667/RADE-21-00053.1.

Meeting Report: A Poly-Pharmacy Approach to Mitigate Acute Radiation Syndrome.

Taliaferro L, Cassatt D, Horta Z, Satyamitra M Radiat Res. 2021; 196(4):436-446.

PMID: 34237144 PMC: 8532024. DOI: 10.1667/RADE-21-00048.1.

Co-Therapy of Pegylated G-CSF and Ghrelin for Enhancing Survival After Exposure to Lethal Radiation.

Kiang J, Zhai M, Lin B, Smith J, Anderson M, Jiang S Front Pharmacol. 2021; 12:628018.

PMID: 33603673 PMC: 7884820. DOI: 10.3389/fphar.2021.628018.

Use of Growth Factors and Cytokines to Treat Injuries Resulting from a Radiation Public Health Emergency.

Horta Z, Case Jr C, DiCarlo A Radiat Res. 2019; 192(1):92-97.

PMID: 31063041 PMC: 8369885. DOI: 10.1667/RR15383.1.

References

Kindler V, Thorens B, de Kossodo S, Allet B, Eliason J, Thatcher D . Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3. Proc Natl Acad Sci U S A. 1986; 83(4):1001-5. PMC: 322998. DOI: 10.1073/pnas.83.4.1001. View

Farese A, Herodin F, McKearn J, Baum C, Burton E, MacVittie T . Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia. Blood. 1996; 87(2):581-91. View

Welte K, Bonilla M, Gillio A, Boone T, Potter G, GABRILOVE J . Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med. 1987; 165(4):941-8. PMC: 2188574. DOI: 10.1084/jem.165.4.941. View

Kobayashi Y, Okabe T, Urabe A, Suzuki N, Takaku F . Human granulocyte colony-stimulating factor produced by Escherichia coli shortens the period of granulocytopenia induced by irradiation in mice. Jpn J Cancer Res. 1987; 78(8):763-6. View

Morstyn G, Campbell L, Souza L, Alton N, Keech J, Green M . Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1988; 1(8587):667-72. DOI: 10.1016/s0140-6736(88)91475-4. View

Ishibashi T, Kimura H, Shikama Y, Uchida T, KARIYONE S, Hirano T . Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood. 1989; 74(4):1241-4. View

Schuening F, Storb R, GOEHLE S, Graham T, Appelbaum F, Hackman R . Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood. 1989; 74(4):1308-13. View

Sheridan W, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D . Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet. 1989; 2(8668):891-5. DOI: 10.1016/s0140-6736(89)91552-3. View

Fushiki M, Ono K, Sasai K, Shibamoto Y, Tsutsui K, Nishidai T . Effect of recombinant human granulocyte colony-stimulating factor on granulocytopenia in mice induced by irradiation. Int J Radiat Oncol Biol Phys. 1990; 18(2):353-7. DOI: 10.1016/0360-3016(90)90100-x. View

10.

Patchen M, MacVittie T, Solberg B, Souza L . Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression. Int J Cell Cloning. 1990; 8(2):107-22. DOI: 10.1002/stem.5530080204. View

11.

MacVittie T, Monroy R, Patchen M, Souza L . Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol. 1990; 57(4):723-36. DOI: 10.1080/09553009014550891. View

12.

Metcalf D, Nicola N, Gearing D . Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood. 1990; 76(1):50-6. View

13.

Navarro S, Debili N, Le Couedic J, Klein B, BRETON-GORIUS J, DOLY J . Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood. 1991; 77(3):461-71. View

14.

Neben T, Loebelenz J, Hayes L, McCarthy K, Stoudemire J, Schaub R . Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood. 1993; 81(4):901-8. View

15.

Methia N, Louache F, Vainchenker W, Wendling F . Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood. 1993; 82(5):1395-401. View

16.

Williams D, Dunn J, Park L, Frieden E, Seiler F, Farese A . A GM-CSF/IL-3 fusion protein promotes neutrophil and platelet recovery in sublethally irradiated rhesus monkeys. Biotechnol Ther. 1993; 4(1-2):17-29. View

17.

Farese A, Williams D, Seiler F, MacVittie T . Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood. 1993; 82(10):3012-8. View

18.

de Sauvage F, Hass P, Spencer S, Malloy B, Gurney A, Spencer S . Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369(6481):533-8. DOI: 10.1038/369533a0. View

19.

Lok S, Kaushansky K, Holly R, Kuijper J, Oort P, Grant F . Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994; 369(6481):565-8. DOI: 10.1038/369565a0. View

20.

Kaushansky K, Lok S, Holly R, Broudy V, Lin N, BAILEY M . Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369(6481):568-71. DOI: 10.1038/369568a0. View